Clinical trial
The Tobramycin Study
NCT00257790 · Oslo University Hospital, Other · Completed
Key facts
| NCT number | NCT00257790 |
|---|---|
| Title | The Tobramycin Study |
| Official title | Tobramycin én Gang Daglig Mot Tre Ganger Daglig, Gitt Med Benzylpenicillin, Til Pasienter Med nøytropen Feber |
| Lead sponsor | Oslo University Hospital, Other |
| Collaborators | The National Institute of Health, Oslo Ullevaal University Hospital Sorlandet Hospital HF Sykehuset Buskerud Sentralsjukehuset i Rogaland Sykehuset Innlandet HF Sentralsjukehuset i Hedemark The… |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Neutropenia, Fever, Cancer |
| Intervention type | Drug |
| Interventions | Tobramycin once a day |
| Enrollment | 210 |
| Start date | Sep 1, 2001 |
| Completion | Mar 1, 2005 |
| First posted | Nov 23, 2005 |
| Last update posted | Jul 6, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: